Monday - July 7, 2025
Cancer drug candidate developed using supercomputing & AI blocks tumor growth without toxic side effect
June 26, 2025
LIVERMORE, California, June 26 -- The U.S. Department of Energy Lawrence Livermore National Laboratory issued the following news:

* * *

Cancer drug candidate developed using supercomputing & AI blocks tumor growth without toxic side effect

*

A new cancer drug candidate developed by Lawrence Livermore National Laboratory (LLNL), (link is external) BBOT (BridgeBio Oncology Therapeutics) and the (link is external) Frederick National Laboratory . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products